siRNAs: their potential as therapeutic agents - Part I. Designing of siRNAs

Praveensingh B. Hajeri; Sunit Kumar Singh

doi:10.1016/j.drudis.2009.06.001

siRNAs: their potential as therapeutic agents - Part I. Designing of siRNAs

Praveensingh B. Hajeri, Sunit Kumar Singh

Surgery

Research output: Contribution to journal › Review article › peer-review

34 Scopus citations

Abstract

RNA interference (RNAi) is a novel and essential biological process, as well as a powerful experimental tool with the potential to be used in therapeutic development. RNAi-based strategies have the capability of being able to be driven from bench to bedside. It is very important to develop the precise tools for designing the siRNAs to get the most efficient knockdown of the target genes and to reduce any off-target effects. In this review we have discussed the strategies and parameters required for effective siRNA designing and synthesis, based on already published literature.

Original language	English (US)
Pages (from-to)	851-858
Number of pages	8
Journal	Drug Discovery Today
Volume	14
Issue number	17-18
DOIs	https://doi.org/10.1016/j.drudis.2009.06.001
State	Published - Sep 2009

Bibliographical note

Funding Information:
Authors are highly thankful to Dr Lalji Singh, Director, Centre for Cellular & Molecular Biology (CCMB), Hyderabad for providing all the necessary support during the preparation of this manuscript. The financial support (Ref: BT/PR10709/AGR/36/598/2008) from the Department of Biotechnology (DBT), Govt. of India, New Delhi is highly acknowledged.

Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.

Publisher link

10.1016/j.drudis.2009.06.001

Find It

Find It at U of M Libraries

Cite this

@article{518ccc07e4c540a18d29adc8c87e873f,

title = "siRNAs: their potential as therapeutic agents - Part I. Designing of siRNAs",

abstract = "RNA interference (RNAi) is a novel and essential biological process, as well as a powerful experimental tool with the potential to be used in therapeutic development. RNAi-based strategies have the capability of being able to be driven from bench to bedside. It is very important to develop the precise tools for designing the siRNAs to get the most efficient knockdown of the target genes and to reduce any off-target effects. In this review we have discussed the strategies and parameters required for effective siRNA designing and synthesis, based on already published literature.",

author = "Hajeri, {Praveensingh B.} and Singh, {Sunit Kumar}",

note = "Funding Information: Authors are highly thankful to Dr Lalji Singh, Director, Centre for Cellular & Molecular Biology (CCMB), Hyderabad for providing all the necessary support during the preparation of this manuscript. The financial support (Ref: BT/PR10709/AGR/36/598/2008) from the Department of Biotechnology (DBT), Govt. of India, New Delhi is highly acknowledged. Copyright: Copyright 2009 Elsevier B.V., All rights reserved.",

year = "2009",

month = sep,

doi = "10.1016/j.drudis.2009.06.001",

language = "English (US)",

volume = "14",

pages = "851--858",

journal = "Drug Discovery Today",

issn = "1359-6446",

publisher = "Elsevier Limited",

number = "17-18",

}

TY - JOUR

T1 - siRNAs

T2 - their potential as therapeutic agents - Part I. Designing of siRNAs

AU - Hajeri, Praveensingh B.

AU - Singh, Sunit Kumar

N1 - Funding Information: Authors are highly thankful to Dr Lalji Singh, Director, Centre for Cellular & Molecular Biology (CCMB), Hyderabad for providing all the necessary support during the preparation of this manuscript. The financial support (Ref: BT/PR10709/AGR/36/598/2008) from the Department of Biotechnology (DBT), Govt. of India, New Delhi is highly acknowledged. Copyright: Copyright 2009 Elsevier B.V., All rights reserved.

PY - 2009/9

Y1 - 2009/9

N2 - RNA interference (RNAi) is a novel and essential biological process, as well as a powerful experimental tool with the potential to be used in therapeutic development. RNAi-based strategies have the capability of being able to be driven from bench to bedside. It is very important to develop the precise tools for designing the siRNAs to get the most efficient knockdown of the target genes and to reduce any off-target effects. In this review we have discussed the strategies and parameters required for effective siRNA designing and synthesis, based on already published literature.

AB - RNA interference (RNAi) is a novel and essential biological process, as well as a powerful experimental tool with the potential to be used in therapeutic development. RNAi-based strategies have the capability of being able to be driven from bench to bedside. It is very important to develop the precise tools for designing the siRNAs to get the most efficient knockdown of the target genes and to reduce any off-target effects. In this review we have discussed the strategies and parameters required for effective siRNA designing and synthesis, based on already published literature.

UR - http://www.scopus.com/inward/record.url?scp=69549105796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69549105796&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2009.06.001

DO - 10.1016/j.drudis.2009.06.001

M3 - Review article

C2 - 19540928

AN - SCOPUS:69549105796

SN - 1359-6446

VL - 14

SP - 851

EP - 858

JO - Drug Discovery Today

JF - Drug Discovery Today

IS - 17-18

ER -

siRNAs: their potential as therapeutic agents - Part I. Designing of siRNAs

Abstract

Bibliographical note

Publisher link

Find It

Other files and links

Fingerprint

Cite this